Cambridge Nutritional Sciences plc Share Price
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.85 GBX | 0.00% | +18.46% | +60.42% |
04-22 | Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named | MT |
04-22 | Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 | CI |
Sales 2024 * | 9M 11.24M 900M | Sales 2025 * | - | Capitalization | 9.16M 11.44M 916M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.25M -100M | Net income 2025 * | - | EV / Sales 2024 * | 0.55 x |
Net cash position 2024 * | 4.2M 5.25M 420M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.7
x | P/E ratio 2025 * |
-
| Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
Latest transcript on Cambridge Nutritional Sciences plc
1 week | +18.46% | ||
Current month | +11.59% | ||
1 month | +10.00% | ||
3 months | +60.42% | ||
6 months | +92.50% | ||
Current year | +60.42% |
Managers | Title | Age | Since |
---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 29/06/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 29/06/11 |
Jeremy Millard
BRD | Director/Board Member | 53 | 28/02/19 |
Carolyn Rand
CHM | Chairman | 60 | 16/08/23 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 3.85 | 0.00% | 623,930 |
25/04/24 | 3.85 | -3.75% | 1,184,714 |
24/04/24 | 4 | 0.00% | 1,861,453 |
23/04/24 | 4 | +8.11% | 3,100,431 |
22/04/24 | 3.7 | +13.85% | 4,653,177 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+60.42% | 11.41M | |
+0.89% | 12.8B | |
-10.29% | 7.61B | |
+1.78% | 5.41B | |
-1.16% | 4.51B | |
+5.74% | 4.49B | |
-50.70% | 3.29B | |
+12.21% | 2.73B | |
-16.13% | 2.02B | |
-11.50% | 1.73B |
- Stock Market
- Equities
- ODX Stock